Applied Therapeutics, Inc

(NASDAQ:APLT)

Latest On Applied Therapeutics, Inc (APLT):

Date/Time Type Description Signal Details
2023-05-25 17:49 ESTNewsApplied Therapeutics' govorestat gets orphan drug tag in EU for muscle disorderN/A
2023-05-12 20:29 ESTNewsApplied Therapeutics files for $300M mixed shelf offeringN/A
2023-05-11 16:38 ESTNewsApplied Therapeutics GAAP EPS of -$0.18 beats by $0.25N/A
2023-04-24 15:29 ESTNewsApplied Therapeutics up 12% on $30M offeringN/A
2023-03-23 15:11 ESTNewsApplied Therapeutics GAAP EPS of -$2.18 beats by $0.44N/A
2023-02-16 10:29 ESTNewsApplied Therapeutics rises ~10% as AT-007 shows efficacy in phase 3 trial for muscle disorderN/A
2023-01-04 16:19 ESTNewsApplied Therapeutics adds 19% on partnership with Advanz Pharma for lead assetN/A
2022-11-09 20:15 ESTNewsApplied Therapeutics GAAP EPS of -$0.40 beats by $0.12N/A
2022-08-12 14:52 ESTNewsApplied Therapeutics GAAP EPS of -$0.96 misses by $0.40N/A
2022-06-23 08:22 ESTNewsApplied Therapeutics launches stock offeringN/A
2022-06-23 08:22 ESTNewsApplied therapeutics stock sinks on pricing $30M equity offeringN/A
2022-06-03 16:37 ESTNewsApplied Therapeutics stock rises on EMA orphan drug status for metabolic disorder drug AT-007N/A
2022-05-12 12:44 ESTNewsApplied Therapeutics GAAP EPS of -$0.88N/A
2022-03-18 11:47 ESTNewsApplied Therapeutics (APLT) Investor Presentation - SlideshowN/A
2022-03-10 12:07 ESTNewsApplied Therapeutics GAAP EPS of -$4.12 beats by $0.31N/A
2022-01-19 08:51 ESTNewsApplied Therapeutics: Buying This Beaten-Down, Undervalued Rare Disease Company's StockN/A
2022-01-04 09:07 ESTNewsApplied Therapeutics plummeted 30% after delay in NDA filingN/A
2022-01-03 16:23 ESTNewsApplied Therapeutics to delay submission of marketing application for galactosemia therapyN/A
2021-11-24 14:05 ESTNewsWarning: APLT is at high risk of performing badlyN/A
2021-11-12 16:45 ESTNewsApplied Therapeutics EPS beats by $0.01N/A
2021-10-25 12:52 ESTNewsApplied Therapeutics highlights biomarker data from pilot trial of AT-007N/A
2021-10-19 05:32 ESTNewsApplied Therapeutics drug benefits kids in rare metabolic disorder, plans Q4 NDA filingN/A
2021-09-09 20:17 ESTNewsApplied Therapeutics delays NDA for rare pediatric metabolic disease candidate to Q4N/A
2021-08-30 07:40 ESTNewsApplied Therapeutics cut to sell at Goldman Sachs citing regulatory and financing risksN/A
2021-08-12 12:19 ESTNewsApplied Therapeutics EPS beats by $0.09N/A
2021-07-20 19:06 ESTNewsApplied Therapeutics trades higher on FDA Fast Track designation for rare metabolic disorderN/A
2021-07-20 18:59 ESTNewsApplied Therapeutics added to Russell Microcap IndexN/A
2021-03-19 04:11 ESTEarnings EstimateAn EPS average of -$4.14 is estimated for the 2022 year.Sell
2021-03-19 04:11 ESTEarnings EstimateAn EPS average of -$1.08 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-18 13:52 ESTNewsApplied Therapeutics EPS beats by $0.26N/A
2021-02-12 14:29 ESTNewsApplied Therapeutics secures $69M via equity offeringN/A
2021-02-11 02:54 ESTNewsApplied Therapeutics plans 3M share public offeringN/A
2021-02-04 07:07 ESTAnalyst RatingThe Analyst Target Price has decreased from $53 to $49.83.Neutral
2021-02-02 21:47 ESTNewsApplied Therapeutics to resume galactosemia study for AT-007N/A
2021-01-20 00:03 ESTNewsApplied Therapeutics And The Murky World Of Biopharma DevelopmentN/A
2020-12-16 01:58 ESTNewsLarimar, Avadel, Applied Therapeutics will added to Nasdaq Biotechnology IndexN/A
2020-12-13 03:12 ESTFinancialsCompany financials have been released.Neutral
2020-11-20 11:08 ESTAnalyst RatingThe Analyst Target Price has decreased from $53.5 to $53.Neutral
2020-11-18 11:08 ESTAnalyst RatingThe Analyst Target Price has decreased from $56.83 to $53.5.Neutral
2020-11-17 03:08 ESTAnalyst RatingThe Analyst Target Price has decreased from $60.5 to $56.83.Neutral
2020-11-15 19:09 ESTFinancialsCompany financials have been released.Neutral
2020-11-15 11:12 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 11:12 ESTEarnings EstimateAn EPS average of -$1.14 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-12 16:59 ESTNewsApplied Therapeutics EPS misses by $0.21N/A
2020-11-01 17:03 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 12:09 ESTAnalyst RatingThe Analyst Target Price has increased from $60.17 to $60.5.Buy
2020-10-30 08:48 ESTInsider TradeRiccardo Perfetti has directly disposed of 465 shares and currently holds 0 shares.Sell
2020-10-30 08:48 ESTInsider TradeRiccardo Perfetti has directly acquired 465 shares and currently holds 465 shares.Buy
2020-10-30 08:48 ESTInsider TradeRiccardo Perfetti has directly disposed of 465 shares and currently holds 0 shares.Sell
2020-10-30 08:48 ESTInsider TradeRiccardo Perfetti has directly acquired 465 shares and currently holds 465 shares.Buy

About Applied Therapeutics, Inc (APLT):

Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that is in phase I/II for the treatment of galactosemia; AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy; and AT-003 that is in phase I clinical trial for the treatment diabetic retinopathy. The company's preclinical stage products include AT-104 for the treatment of orphan hematological oncology. Applied Therapeutics, Inc. was founded in 2016 and is headquartered in New York, New York.

APLT Quotes by TradingView

See Advanced Chart

General

  • Name Applied Therapeutics, Inc
  • Symbol APLT
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 22
  • Fiscal Year EndDecember
  • IPO Date2019-05-14
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.appliedtherapeutics.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 4.96
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Current Year EPS Estimate -$4.47
  • Next Year EPS Estimate -$4.14
  • Next Quarter EPS Estimate -$1.08
  • Return on Assets -68%
  • Return on Equity -132%
  • Earnings Per Share -$3.69
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 519.91 million
  • Analyst Target Price $49.83
  • Book Value Per Share $4.58
View More

Share Statistics

  • Shares Outstanding 25.94 million
  • Shares Float 12.11 million
  • % Held by Insiders 2388%
  • % Held by Institutions 71.47%
  • Shares Short 1.23 million
  • Shares Short Prior Month 1.62 million
  • Short Ratio 7.17
  • Short % of Float 7%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • 52 Week High $51.99
  • 52 Week Low $13.58
  • 50 Day Moving Average 22.08
  • 200 Day Moving Average 21.59
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Applied Therapeutics, Inc (APLT) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Applied Therapeutics, Inc (APLT) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31-$1.06-$1.2515.2%
2020-09-302020-11-12$N/A-$1.33-$0.89-48.99%
2020-06-302020-08-11$N/A-$1.27-$0.68-85.75%
2020-03-312020-05-11$N/A-$0.59-$0.8429.48%
2019-12-312020-03-13$N/A-$1.57-$0.64-145.73%
2019-09-302019-11-13$N/A-$0.63-$0.44-42.63%
2019-06-302019-08-12$N/A-$0.60-$0.43-39.89%
2019-03-312019-06-21$N/A-$0.67-$0.39-71.79%

Applied Therapeutics, Inc (APLT) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Applied Therapeutics, Inc (APLT) Chart:

Applied Therapeutics, Inc (APLT) News:

Below you will find a list of latest news for Applied Therapeutics, Inc (APLT) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Applied Therapeutics, Inc (APLT) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50CALL0 0379.84TRUE00
2024-05-1750.2CALL0 269104.05FALSE00
2024-05-177.50.01CALL0 11220FALSE00
2024-05-17100.07CALL0 12550FALSE00
2024-05-1712.50.1CALL0 6730FALSE00
2024-05-172.50.07PUT0 3620FALSE00
2024-05-1751.05PUT143 872136.13TRUE0.140.15
2024-05-177.52.35PUT0 0197.78TRUE00
2024-05-17100PUT0 0201.29TRUE00
2024-05-1712.50PUT0 0241.56TRUE00
2024-06-212.50CALL0 0256.61TRUE00
2024-06-2150.4CALL0 495.16FALSE00
2024-06-217.50.05CALL0 1020FALSE00
2024-06-21100CALL0 00FALSE00
2024-06-212.50PUT0 00FALSE00
2024-06-2150PUT0 089.8TRUE00
2024-06-217.50PUT0 0113.78TRUE00
2024-06-21100PUT0 0166.4TRUE00
2024-07-192.52.22CALL0 390104.21TRUE00
2024-07-1950.53CALL0 254795.78FALSE00
2024-07-197.50.15CALL4 275898.48FALSE0.150
2024-07-19100.1CALL0 42860FALSE00
2024-07-1912.50.35CALL0 10FALSE00
2024-07-19150.36CALL0 1380FALSE00
2024-07-1917.50.15CALL0 6070FALSE00
2024-07-192.50.15PUT0 293107.38FALSE00
2024-07-1950.7PUT0 63090.65TRUE00
2024-07-197.53PUT0 4383.07TRUE00
2024-07-19100PUT0 0139.95TRUE00
2024-07-1912.50PUT0 0137.05TRUE00
2024-07-19150PUT0 0221.15TRUE00
2024-07-1917.50PUT0 0211.32TRUE00
2024-10-182.52.5CALL0 17145.57TRUE00
2024-10-1851.2CALL0 798118.66FALSE00
2024-10-187.50.58CALL276 844111.5FALSE0.580
2024-10-18100.48CALL0 1365112.95FALSE00
2024-10-1812.51.2CALL0 100114.07FALSE00
2024-10-18150.5CALL0 93114.68FALSE00
2024-10-1817.50.08CALL25 173109.75FALSE0.080
2024-10-182.50.46PUT0 1572121.71FALSE00
2024-10-1851.65PUT0 113115.56TRUE00
2024-10-187.53.5PUT0 8110.63TRUE00
2024-10-18100PUT0 0104.65TRUE00
2024-10-1812.50PUT0 0105.25TRUE00
2024-10-18150PUT0 0183.11TRUE00
2024-10-1817.50PUT0 0175.92TRUE00
2025-01-172.52.6CALL32 501146.69TRUE2.60
2025-01-1751.55CALL10 277124.29FALSE-0.05-0.03
2025-01-177.51CALL0 12147.05FALSE00
2025-01-17101.25CALL0 20101.15FALSE00
2025-01-1712.51.34CALL0 7116.84FALSE00
2025-01-172.50.65PUT0 29130.62FALSE00
2025-01-1751.95PUT0 1169.21TRUE00
2025-01-177.50PUT0 0168.63TRUE00
2025-01-17100PUT0 0167.25TRUE00
2025-01-1712.50PUT0 0170.78TRUE00
2026-01-162.50CALL0 0123.58TRUE00
2026-01-1652.7CALL0 6123.76FALSE00
2026-01-167.50CALL0 00FALSE00
2026-01-16100CALL0 00FALSE00
2026-01-1612.50CALL0 00FALSE00
2026-01-162.50PUT0 0107.62FALSE00
2026-01-1650PUT0 0120.22TRUE00
2026-01-167.50PUT0 0106.63TRUE00
2026-01-16100PUT0 0112.56TRUE00
2026-01-1612.50PUT0 098.83TRUE00

Latest APLT Trades:

Date Shares Price
Jun 13, 2022 7:53 PM EST86$1.265
Jun 13, 2022 7:55 PM EST10$1.265
Jun 13, 2022 7:58 PM EST10$1.265
Jun 13, 2022 7:58 PM EST50$1.265
Jun 13, 2022 7:58 PM EST43$1.265

Applied Therapeutics, Inc (APLT) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm
2019-02-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1697532/000000000019002467/0000000000-19-002467-index.htm
2019-03-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1697532/000000000019005376/0000000000-19-005376-index.htm
2019-12-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1697532/000000000019016551/0000000000-19-016551-index.htm
2020-01-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1697532/000000000020000456/0000000000-20-000456-index.htm
2020-06-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1697532/000000000020005144/0000000000-20-005144-index.htm
2020-08-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1697532/000031506620001680/0000315066-20-001680-index.htm
2019-01-25DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1697532/000091205719000026/0000912057-19-000026-index.htm
2019-03-08DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1697532/000091205719000080/0000912057-19-000080-index.htm
2019-03-27DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1697532/000091205719000125/0000912057-19-000125-index.htm
2020-01-10DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1697532/000091205720000011/0000912057-20-000011-index.htm
2017-02-08DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000091476017000017/0000914760-17-000017-index.htm
2019-11-21DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000095017219000131/0000950172-19-000131-index.htm
2019-05-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000103544319000140/0001035443-19-000140-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000103544319000142/0001035443-19-000142-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000103544320000079/0001035443-20-000079-index.htm
2019-04-12S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1697532/000104746919002204/0001047469-19-002204-index.htm
2019-04-24S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1697532/000104746919002548/0001047469-19-002548-index.htm
2019-04-29S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1697532/000104746919002659/0001047469-19-002659-index.htm
2019-05-14424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1697532/000104746919003094/0001047469-19-003094-index.htm
2019-12-13S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1697532/000104746919006843/0001047469-19-006843-index.htm
2019-12-19S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1697532/000104746919006897/0001047469-19-006897-index.htm
2019-12-23424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1697532/000104746919006940/0001047469-19-006940-index.htm
2020-01-21S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1697532/000104746920000339/0001047469-20-000339-index.htm
2020-01-23S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1697532/000104746920000444/0001047469-20-000444-index.htm
2020-01-24424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1697532/000104746920000481/0001047469-20-000481-index.htm
2020-03-16POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1697532/000104746920001490/0001047469-20-001490-index.htm
2020-04-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1697532/000104746920002463/0001047469-20-002463-index.htm
2019-04-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1697532/000110465919023277/0001104659-19-023277-index.htm
2019-05-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1697532/000110465919027139/0001104659-19-027139-index.htm
2019-05-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1697532/000110465919027140/0001104659-19-027140-index.htm
2019-05-068-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1697532/000110465919027141/0001104659-19-027141-index.htm
2019-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465919030034/0001104659-19-030034-index.htm
2019-05-20S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1697532/000110465919030598/0001104659-19-030598-index.htm
2019-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465919031803/0001104659-19-031803-index.htm
2019-05-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1697532/000110465919032050/0001104659-19-032050-index.htm
2019-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465919032065/0001104659-19-032065-index.htm
2019-05-29SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1697532/000110465919032185/0001104659-19-032185-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465919034283/0001104659-19-034283-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465919034409/0001104659-19-034409-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465919036821/0001104659-19-036821-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465919037098/0001104659-19-037098-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465919044149/0001104659-19-044149-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465919044692/0001104659-19-044692-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465919045179/0001104659-19-045179-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465919048585/0001104659-19-048585-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465919048732/0001104659-19-048732-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465919062212/0001104659-19-062212-index.htm
2019-12-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1697532/000110465919073728/0001104659-19-073728-index.htm
2020-01-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1697532/000110465920005582/0001104659-20-005582-index.htm
2020-01-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1697532/000110465920005586/0001104659-20-005586-index.htm
2020-01-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1697532/000110465920005844/0001104659-20-005844-index.htm
2020-01-23S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1697532/000110465920006417/0001104659-20-006417-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1697532/000110465920021996/0001104659-20-021996-index.htm
2020-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465920021999/0001104659-20-021999-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465920032753/0001104659-20-032753-index.htm
2020-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465920041936/0001104659-20-041936-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465920049003/0001104659-20-049003-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465920059092/0001104659-20-059092-index.htm
2020-05-11424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1697532/000110465920059123/0001104659-20-059123-index.htm
2020-05-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465920065642/0001104659-20-065642-index.htm
2020-06-01SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1697532/000110465920068461/0001104659-20-068461-index.htm
2020-06-05S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1697532/000110465920069963/0001104659-20-069963-index.htm
2020-06-05POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1697532/000110465920069971/0001104659-20-069971-index.htm
2020-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465920070364/0001104659-20-070364-index.htm
2020-06-12S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1697532/000110465920072958/0001104659-20-072958-index.htm
2020-06-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1697532/000110465920072971/0001104659-20-072971-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465920092998/0001104659-20-092998-index.htm
2020-08-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1697532/000110465920095670/0001104659-20-095670-index.htm
2020-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000110465920095852/0001104659-20-095852-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1697532/000114036120009524/0001140361-20-009524-index.htm
2020-04-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1697532/000114036120009526/0001140361-20-009526-index.htm
2018-02-20DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000114420418009827/0001144204-18-009827-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1697532/000117266120000918/0001172661-20-000918-index.htm
2019-05-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119029499/0001209191-19-029499-index.htm
2019-05-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119029500/0001209191-19-029500-index.htm
2019-05-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119029501/0001209191-19-029501-index.htm
2019-05-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119029502/0001209191-19-029502-index.htm
2019-05-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119029503/0001209191-19-029503-index.htm
2019-05-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119029504/0001209191-19-029504-index.htm
2019-05-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119029505/0001209191-19-029505-index.htm
2019-05-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119029506/0001209191-19-029506-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119030074/0001209191-19-030074-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119030078/0001209191-19-030078-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119030080/0001209191-19-030080-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119030081/0001209191-19-030081-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119030083/0001209191-19-030083-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119030085/0001209191-19-030085-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119030088/0001209191-19-030088-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119031447/0001209191-19-031447-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119031448/0001209191-19-031448-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119031450/0001209191-19-031450-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119031452/0001209191-19-031452-index.htm
2019-05-293/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119033218/0001209191-19-033218-index.htm
2019-05-294/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119033219/0001209191-19-033219-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119034754/0001209191-19-034754-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119061180/0001209191-19-061180-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919119061182/0001209191-19-061182-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120005367/0001209191-20-005367-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120005368/0001209191-20-005368-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120007706/0001209191-20-007706-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120009468/0001209191-20-009468-index.htm
2020-03-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120016701/0001209191-20-016701-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120018230/0001209191-20-018230-index.htm
2020-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120023447/0001209191-20-023447-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm
2020-05-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120032167/0001209191-20-032167-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120033310/0001209191-20-033310-index.htm
2020-06-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120033313/0001209191-20-033313-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120034593/0001209191-20-034593-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120034791/0001209191-20-034791-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120034792/0001209191-20-034792-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120034793/0001209191-20-034793-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120034794/0001209191-20-034794-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120034795/0001209191-20-034795-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120035769/0001209191-20-035769-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120037485/0001209191-20-037485-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120038359/0001209191-20-038359-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm
2020-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm
2020-08-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120048318/0001209191-20-048318-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120053946/0001209191-20-053946-index.htm
2020-10-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120056273/0001209191-20-056273-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000120919120056497/0001209191-20-056497-index.htm
2019-05-07CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1697532/000135445719000258/0001354457-19-000258-index.htm
2019-03-08DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1697532/000141057819000127/0001410578-19-000127-index.htm
2019-03-27DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1697532/000141057819000157/0001410578-19-000157-index.htm
2019-06-2110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1697532/000155837019005822/0001558370-19-005822-index.htm
2019-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1697532/000155837019007973/0001558370-19-007973-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1697532/000155837019010886/0001558370-19-010886-index.htm
2019-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1697532/000155837019010931/0001558370-19-010931-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1697532/000155837020002630/0001558370-20-002630-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1697532/000155837020006110/0001558370-20-006110-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1697532/000155837020010266/0001558370-20-010266-index.htm
2018-11-19DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1697532/000169753218000002/0001697532-18-000002-index.htm
2019-05-13EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1697532/999999999519001102/9999999995-19-001102-index.htm
2019-12-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1697532/999999999519002895/9999999995-19-002895-index.htm
2020-01-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1697532/999999999520000151/9999999995-20-000151-index.htm
2020-03-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1697532/999999999520000607/9999999995-20-000607-index.htm
2020-06-09EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1697532/999999999520001375/9999999995-20-001375-index.htm
2020-06-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1697532/999999999520001430/9999999995-20-001430-index.htm

Applied Therapeutics, Inc (APLT) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Applied Therapeutics, Inc (APLT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2388%
Institutional Ownership: 7147%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-10-27Riccardo PerfettiChief Medical OfficerSell465.0021.209,858.000.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120056273/0001209191-20-056273-index.htm
2020-10-28Riccardo PerfettiChief Medical OfficerSell465.0018.498,597.850.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120056273/0001209191-20-056273-index.htm
2020-10-29Riccardo PerfettiChief Medical OfficerSell465.0017.278,030.550.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120056273/0001209191-20-056273-index.htm
2020-05-29Leslie D. FuntleyderDirectorSell8,495.0045.08382,954.6017,148.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120033313/0001209191-20-033313-index.htm
2020-06-04Leslie D. FuntleyderDirectorSell1,482.0044.1765,459.9417,148.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120034593/0001209191-20-034593-index.htm
2020-06-10Leslie D. FuntleyderDirectorSell2,563.0042.83109,773.2917,148.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120035769/0001209191-20-035769-index.htm
2020-06-18Leslie D. FuntleyderDirectorSell11.0045.90504.9017,148.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120038359/0001209191-20-038359-index.htm
2020-06-25Leslie D. FuntleyderDirectorSell100.0038.283,828.0017,148.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm
2020-08-24Leslie D. FuntleyderDirectorSell6,461.0024.18156,226.9817,148.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120048318/0001209191-20-048318-index.htm
2020-10-02Leslie D. FuntleyderDirectorSell5,976.0020.07119,938.3217,148.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120053946/0001209191-20-053946-index.htm
2020-06-18Leslie D. FuntleyderDirectorSell7,487.0045.32339,310.8417,159.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120038359/0001209191-20-038359-index.htm
2020-06-25Leslie D. FuntleyderDirectorSell517.0037.5219,397.8417,248.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm
2020-06-25Leslie D. FuntleyderDirectorSell200.0036.127,224.0017,765.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm
2020-06-24Leslie D. FuntleyderDirectorSell400.0040.9216,368.0017,965.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm
2020-06-24Leslie D. FuntleyderDirectorSell3,811.0040.41154,002.5118,365.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm
2020-06-03Leslie D. FuntleyderDirectorSell1,032.0044.0345,438.9618,630.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120034593/0001209191-20-034593-index.htm
2020-06-02Leslie D. FuntleyderDirectorSell12,486.0045.21564,492.0619,662.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120034593/0001209191-20-034593-index.htm
2020-06-10Leslie D. FuntleyderDirectorSell2,622.0041.80109,599.6019,711.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120035769/0001209191-20-035769-index.htm
2020-06-24Leslie D. FuntleyderDirectorSell3,572.0039.20140,022.4022,176.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm
2020-06-09Leslie D. FuntleyderDirectorSell1,500.0044.8767,305.0022,333.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120035769/0001209191-20-035769-index.htm
2020-10-01Leslie D. FuntleyderDirectorSell1,353.0020.7528,074.7523,124.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120053946/0001209191-20-053946-index.htm
2020-08-24Leslie D. FuntleyderDirectorSell13,539.0023.42317,083.3823,609.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120048318/0001209191-20-048318-index.htm
2020-06-09Leslie D. FuntleyderDirectorSell2,000.0042.8285,640.0023,833.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120035769/0001209191-20-035769-index.htm
2020-10-01Leslie D. FuntleyderDirectorSell22,671.0020.03454,100.1324,477.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120053946/0001209191-20-053946-index.htm
2020-06-17Leslie D. FuntleyderDirectorSell4,100.0044.15181,015.0024,646.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120037485/0001209191-20-037485-index.htm
2020-05-29Leslie D. FuntleyderDirectorSell7,120.0044.27315,202.4025,643.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120033313/0001209191-20-033313-index.htm
2020-06-23Leslie D. FuntleyderDirectorSell1,340.0047.4063,516.0025,748.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm
2020-06-08Leslie D. FuntleyderDirectorSell8,315.0044.77372,262.5525,833.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120035769/0001209191-20-035769-index.htm
2020-06-23Leslie D. FuntleyderDirectorSell160.0046.457,432.0027,088.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm
2020-06-23Leslie D. FuntleyderDirectorSell1,809.0045.3582,038.1527,248.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm
2020-06-16Leslie D. FuntleyderDirectorSell100.0045.184,518.0028,746.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120037485/0001209191-20-037485-index.htm
2020-06-16Leslie D. FuntleyderDirectorSell5,302.0044.37235,249.7428,846.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120037485/0001209191-20-037485-index.htm
2020-06-23Leslie D. FuntleyderDirectorSell3,462.0044.54154,197.4829,057.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm
2020-06-02Leslie D. FuntleyderDirectorBuy15,000.004.7070,500.0032,148.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120034593/0001209191-20-034593-index.htm
2020-06-23Leslie D. FuntleyderDirectorSell4,629.0043.32200,528.2832,519.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120039034/0001209191-20-039034-index.htm
2020-05-28Leslie D. FuntleyderDirectorSell2,838.0048.27136,990.2632,763.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120033313/0001209191-20-033313-index.htm
2020-06-08Leslie D. FuntleyderDirectorBuy17,000.004.7079,900.0034,148.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120035769/0001209191-20-035769-index.htm
2020-06-15Leslie D. FuntleyderDirectorBuy17,000.004.7079,900.0034,148.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120037485/0001209191-20-037485-index.htm
2020-05-28Leslie D. FuntleyderDirectorBuy18,453.000.04738.1235,601.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120033313/0001209191-20-033313-index.htm
2019-05-16Shoshana ShendelmanPresident and CEOBuy125,000.0010.001,250,000.003,605,662.00https://www.sec.gov/Archives/edgar/data/1697532/000120919119031452/0001209191-19-031452-index.htm
2020-03-09Adam HansardChief Commercial OfficerBuy36,464.0036,464.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120018230/0001209191-20-018230-index.htm
2020-05-15JOEL S MARCUSDirectorSell100.0043.694,369.00365,360.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm
2020-05-15JOEL S MARCUSDirectorSell5,723.0043.20247,233.60365,460.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm
2020-05-14JOEL S MARCUSDirectorSell9,177.0043.18396,262.86371,183.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm
2020-06-22Leslie D. FuntleyderDirectorBuy20,000.004.7094,000.0037,148.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120038359/0001209191-20-038359-index.htm
2020-08-21Leslie D. FuntleyderDirectorSell20,000.004.7094,000.0037,148.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120048318/0001209191-20-048318-index.htm
2020-02-06Teena LernerDirectorBuy18,453.001.0018,453.0037,623.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120007706/0001209191-20-007706-index.htm
2020-05-13JOEL S MARCUSDirectorSell2,017.0049.66100,164.22380,360.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm
2020-05-13JOEL S MARCUSDirectorSell2,202.0048.77107,391.54382,377.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm
2020-05-13JOEL S MARCUSDirectorSell1,600.0047.8876,608.00384,579.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm
2020-05-13JOEL S MARCUSDirectorSell2,012.0046.6193,779.32386,179.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm
2020-05-13JOEL S MARCUSDirectorSell500.0045.2922,645.00388,191.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm
2020-05-13JOEL S MARCUSDirectorSell5,905.0044.46262,536.30388,691.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm
2020-05-13JOEL S MARCUSDirectorSell10,764.0043.60469,310.40394,596.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120029844/0001209191-20-029844-index.htm
2019-05-16JOEL S MARCUSDirectorBuy150,000.0010.001,500,000.00404,860.00https://www.sec.gov/Archives/edgar/data/1697532/000120919119031450/0001209191-19-031450-index.htm
2020-01-28JOEL S MARCUSDirectorBuy500.0045.5022,750.00405,360.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120005368/0001209191-20-005368-index.htm
2020-10-27Riccardo PerfettiChief Medical OfficerBuy465.001.44669.60465.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120056273/0001209191-20-056273-index.htm
2020-10-28Riccardo PerfettiChief Medical OfficerBuy465.001.44669.60465.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120056273/0001209191-20-056273-index.htm
2020-10-29Riccardo PerfettiChief Medical OfficerBuy465.001.44669.60465.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120056273/0001209191-20-056273-index.htm
2020-10-01Leslie D. FuntleyderDirectorSell30,000.004.70141,000.0047,148.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120053946/0001209191-20-053946-index.htm
2020-02-06Teena LernerDirectorBuy11,970.004.7056,259.0049,593.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120007706/0001209191-20-007706-index.htm
2020-05-28Shoshana ShendelmanPresident and CEOSell125,000.0042.705,337,500.00554,285.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120033310/0001209191-20-033310-index.htm
2020-07-07Shoshana ShendelmanPresident and CEOSell13,005.0032.25419,411.25554,285.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm
2020-07-08Shoshana ShendelmanPresident and CEOSell2,111.0032.9869,620.78554,285.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm
2020-07-09Shoshana ShendelmanPresident and CEOSell4,064.0031.64128,584.96554,285.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm
2020-07-20Shoshana ShendelmanPresident and CEOSell300.0028.648,592.00554,285.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm
2020-07-21Shoshana ShendelmanPresident and CEOSell100.0028.242,824.00554,285.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm
2020-07-22Shoshana ShendelmanPresident and CEOSell2,949.0026.5178,177.99554,285.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm
2020-07-21Shoshana ShendelmanPresident and CEOSell7,300.0027.42200,166.00554,385.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm
2020-07-20Shoshana ShendelmanPresident and CEOSell2,600.0027.8872,488.00554,585.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm
2020-07-08Shoshana ShendelmanPresident and CEOSell12,889.0032.21415,154.69556,396.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm
2020-07-20Shoshana ShendelmanPresident and CEOSell12,100.0027.19328,999.00557,185.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm
2020-07-22Shoshana ShendelmanPresident and CEOSell12,051.0025.45306,697.95557,235.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm
2020-07-09Shoshana ShendelmanPresident and CEOSell10,936.0030.90337,922.40558,349.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm
2020-07-21Shoshana ShendelmanPresident and CEOSell7,600.0026.69202,844.00561,685.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm
2020-07-07Shoshana ShendelmanPresident and CEOSell1,995.0031.6363,101.85567,290.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm
2020-07-07Shoshana ShendelmanPresident and CEOBuy15,000.001.4421,600.00569,285.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm
2020-07-08Shoshana ShendelmanPresident and CEOBuy15,000.001.4421,600.00569,285.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm
2020-07-09Shoshana ShendelmanPresident and CEOBuy15,000.001.4421,600.00569,285.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120042085/0001209191-20-042085-index.htm
2020-07-20Shoshana ShendelmanPresident and CEOBuy15,000.001.4421,600.00569,285.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm
2020-07-21Shoshana ShendelmanPresident and CEOBuy15,000.001.4421,600.00569,285.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm
2020-07-22Shoshana ShendelmanPresident and CEOBuy15,000.001.4421,600.00569,285.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120043427/0001209191-20-043427-index.htm
2020-05-28Shoshana ShendelmanPresident and CEOBuy27,624.001.0027,624.00581,909.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120033310/0001209191-20-033310-index.htm
2020-06-04Charles SilbersteinChief Financial OfficerBuy61,000.0061,000.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120034794/0001209191-20-034794-index.htm
2020-01-28Stacy J. KanterDirectorBuy6,500.0045.50295,750.006,500.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120005367/0001209191-20-005367-index.htm
2020-05-28Shoshana ShendelmanPresident and CEOBuy97,376.001.44140,221.44679,285.00https://www.sec.gov/Archives/edgar/data/1697532/000120919120033310/0001209191-20-033310-index.htm
2019-05-16ALEXANDRIA REAL ESTATE EQUITIES INC10% Share HolderBuy975,000.0010.009,750,000.00975,000.00https://www.sec.gov/Archives/edgar/data/1697532/000103544319000142/0001035443-19-000142-index.htm